Sound Income Strategies’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-837
Closed -$41.9K 1662
2026
Q1
$41.9K Hold
837
﹤0.01% 881
2025
Q4
$35K Sell
837
-40
-5% -$1.09K ﹤0.01% 929
2025
Q3
$24.1K Hold
877
﹤0.01% 761
2025
Q2
$24.2K Sell
877
-232
-21% -$6.11K ﹤0.01% 711
2025
Q1
$31.4K Hold
1,109
﹤0.01% 615
2024
Q4
$46.1K Buy
1,109
+32
+3% +$1.53K ﹤0.01% 486
2024
Q3
$72K Hold
1,077
﹤0.01% 388
2024
Q2
$128K Hold
1,077
0.01% 291
2024
Q1
$115K Buy
1,077
+315
+41% +$31.8K 0.01% 286
2023
Q4
$75.8K Buy
762
+115
+18% +$9.67K 0.01% 335
2023
Q3
$66.8K Sell
647
-13
-2% -$1.45K 0.01% 264
2023
Q2
$80.2K Buy
660
+60
+10% +$8K 0.01% 241
2023
Q1
$92.1K Hold
600
0.01% 207
2022
Q4
$108K Hold
600
0.01% 185
2022
Q3
$71K Hold
600
0.01% 196
2022
Q2
$86K Hold
600
0.01% 176
2022
Q1
$103K Hold
600
0.01% 173
2021
Q4
$152K Sell
600
-45
-7% -$13.2K 0.02% 153
2021
Q3
$248K Buy
645
+292
+83% +$108K 0.03% 130
2021
Q2
$83K Buy
353
+103
+41% +$18.4K 0.01% 185
2021
Q1
$32.7K Hold
250
0.01% 278
2020
Q4
$26K Sell
250
-150
-38% -$15.2K 0.01% 284
2020
Q3
$28K Hold
400
0.01% 248
2020
Q2
$26K Buy
+400
New +$21.9K 0.01% 235

Other funds holding MRNA

Sound Income Strategies's MRNA Position: Q2 2026 in Review

Sound Income Strategies sold out of Moderna (MRNA) in Q2 2026, closing a stake of 837 shares — an estimated $41.9K sold.

Sound Income Strategies first reported a position in MRNA in Q2 2020 and held it in 24 quarters. The position peaked at $248K in Q3 2021. 542 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Sound Income Strategies reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 837 Moderna shares in Q2 2026, an estimated $41.9K.
  • Sound Income Strategies first reported a position in Moderna in Q2 2020 and held it in 24 quarters.
  • Sound Income Strategies's Moderna position peaked at $248K in Q3 2021.
  • 542 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.